Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Austen

Alfred R. Austen, Bath, PA US

Patent application number	Description	Published
20120006087	METHOD AND APPARATUS FOR APPLYING UNIAXIAL COMPRESSION STRESSES TO A MOVING WIRE - An apparatus and method for moving a wire along its own axis against a high resistance to its motion causing a substantial uniaxial compression stress in the wire without allowing it to buckle. The apparatus consists of a wire gripping and moving drive wheel and guide rollers for transporting the moving wire away from the drive wheel. Wire is pressed into a peripheral groove in a relatively large diameter, rotating drive wheel by a set of small diameter rollers arranged along part of the periphery causing the wire to be gripped by the groove.	01-12-2012

Christopher H. Austen, Pflugerville, TX US

Patent application number	Description	Published
20080263288	System and Method for Probing Hypervisor Tasks in an Asynchronous Environment - A system, method, and computer-usable medium for probing hypervisor tasks in an asynchronous environment. According to an embodiment of the invention, the partition firmware sends a request for data to the hypervisor. When the hypervisor receives the request for data, the hypervisor returns a taskID that identifies the task allocated to handle the request. Partition firmware records the taskID and a timestamp, which indicates the time in which the hypervisor received the request. A timer is set to measure the amount of time elapsed since the task ID was received by a requesting partition firmware. If the hypervisor has not provided the partition firmware with the requested data after a predetermined time period measured by the timer has elapsed, the partition firmware inquires about the status of the task associated with the taskID. If the task is still running, the partition firmware returns control of the partition to the operating system.	10-23-2008

Christopher Harry Austen, Pflugerville, TX US

Patent application number	Description	Published
20090089624	MECHANISM TO REPORT OPERATING SYSTEM EVENTS ON AN INTELLIGENT PLATFORM MANAGEMENT INTERFACE COMPLIANT SERVER - The exemplary embodiments provide a computer-implemented method, apparatus, and computer-usable program code for reporting operating system faults on an Intelligent Platform Management Interface compliant server. In response to receiving an alert for an operating system fault, the alert for the operating system fault is converted into an IPMI event. The IPMI event is stored in an internal event log. An IPMI system event record is created for the IPMI event. The IPMI event is sent to a host management controller in order to enable monitoring of the operating system fault.	04-02-2009

Malcolm Austen, Middlesex GB

Patent application number	Description	Published
20090305397	Cellular entity maturation and transportation systems - A device for transporting at least one cellular entity during culture or maturation, the device comprising a substrate having one or more wells, said one or more wells being adapted to hold a cellular entity in a fluid, lid means for preventing entry or exit of the cellular entity from the one or more wells and fluid transport means connecting the one or more wells to enable flow of fluid or diffusion of chemical species. The apparatus alternatively or in addition comprise a module for transporting a payload at a controlled temperature, the module comprising an outer housing, an outer thermally insulating region, an inner thermally insulating region, and a heat sinking region located between the inner and outer thermally insulating regions, the inner thermally insulating region defining a cavity for receiving a payload, and heating means.	12-10-2009

Malcolm T. Austen, Middlesex GB

Patent application number	Description	Published
20100196871	APPARATUS AND METHODS FOR CULTURING AND/OR TRANSPORTING CELLULAR STRUCTURES - An apparatus for culturing and/or transporting embryos, oocytes or other cellular structures, comprising a housing (	08-05-2010

Matthias Austen, Goettingen DE

Patent application number	Description	Published
20100247517	USE OF MNK INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The present invention relates to the use of modulators of the kinase activity of Mnk1 and/or Mnk2 the diagnosis, alleviation, treatment and/or prevention of a tauopathy. Particularly, the present invention relates to the use of a modulator of Mnk1 and/or Mnk2 kinase for the diagnosis, alleviation, treatment and/or prevention of Alzheimer's disease. Preferably, the compounds are condensed pyrimidines.	09-30-2010
20110003741	NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE - The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability.	01-06-2011
20110212102	HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.	09-01-2011
20110212103	THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula	09-01-2011
20110217311	CYCLOALKYL CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula	09-08-2011
20110277045	METHODS FOR INCREASING BETA CELL MASS COMPRISING ADMINISTERING A RA770 POLYPEPTIDE - The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders.	11-10-2011

Matthias Austen, Göttingen DE

Patent application number	Description	Published
20080207594	Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders - This invention relates to the use of Pax4 stimulating compounds, e.g. Glycogen synthase kinase-3 (GSK-3) inhibitors, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA. More particularly, this invention relates to the use of compounds selected from paullones, indirubines, substituted ureas, maleimide derivatives and pyrimidine thiones. Further, the present invention relates to a method of identifying and/or characterizing pancreatic beta-cell mitogens by using cells expressing a pancreatic gene or a gene whose function is controlled by a pancreatic gene, particularly the Pax4 gene, and which are transfected with a reporter gene.	08-28-2008
20080241106	Method for Preventing and Treating Diabetes Using Neurturin - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product.	10-02-2008
20090258829	NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN - The present invention relates to formulations with protein growth factors, particularly neurturin as active ingredients and low molecular weight polyanionic excipients having increased bioavailability.	10-15-2009
20110256113	METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product.	10-20-2011

Matthias Austen, Göttingen DE

Patent application number	Description	Published
20090258829	NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN - The present invention relates to formulations with protein growth factors, particularly neurturin as active ingredients and low molecular weight polyanionic excipients having increased bioavailability.	10-15-2009

Paul M. Austen, Milwaukie, OR US

Patent application number	Description	Published
20090124131	THERMOCOUPLE ADAPTER - An adapter is disclosed that allows simplified connection of thermocouples to a data logger. In one embodiment, multiple thermocouple connectors are positioned within the adapter. The adapter then attaches to a data logger with a simple male/female connection scheme so that the multiple thermocouple connectors are simultaneously coupled to the data logger. The thermocouple connectors are already organized within the adapter so that each thermocouple is plugged into its proper location on the data logger.	05-14-2009

Tim Austen, Glencoe, IL US

Patent application number	Description	Published
20100290931	HAND-ACTUATED PUMP - A hand-actuated pump includes a cylinder with a proximal end and a distal end. The distal end defines an opening. The hand-actuated pump also includes a piston with a proximal end. The proximal end of the piston is configured to be slidably inserted into the distal end of the cylinder. An exhaust port is positioned at the proximal end of the cylinder and includes a coupler that is configured to be removably attached to an inflatable object and to communicate air to the inflatable object. The coupler is also configured to be selectively locked in an extended position and a closed position.	11-18-2010

Timothy F. Austen, Glencoe, IL US

Patent application number	Description	Published
20080256717	Inflatable Two Chamber Bed with Raised Headboard - An inflatable mattress. The inflatable mattress comprises a support system having upper and lower inflatable support chambers arranged in a substantially vertical manner and an inflatable headboard chamber arranged in a substantially perpendicular manner to the upper and lower inflatable chambers. Each inflatable support chamber comprises a top layer and a bottom layer. The inflatable mattress may further comprise an inflatable reinforcing chamber disposed between the upper and lower inflatable support chambers and attached to the lower inflatable support chamber.	10-23-2008
20080286117	Pump with automatic deactivation mechanism - An automatic deactivation mechanism is configured for an air bladder pump having a casing and a motor located therein to pump air into an air bladder from the atmosphere and through an air valve connected through the casing. The automatic deactivation mechanism includes a housing positioned within the casing and has defined therethrough a first aperture in fluid communication with the atmosphere through the casing and a second aperture in fluid communication with the air bladder through the casing. Included within the housing are at least two switches and a diaphragm positioned between the switches. The housing is sealed so that when a threshold pressure is reached therein, at least one switch is triggered by deflection of the diaphragm to automatically deactivate the pump by de-energizing the motor.	11-20-2008
20080286124	PUMP FOR INFLATABLE OBJECTS WITH INTEGRATED LIGHT SOURCE - A pump for inflatable objects having a housing including an air inlet and an air outlet, a motor positioned within said housing, an impeller positioned within the housing for moving air, a light source defined on an exterior of the housing; and a reflector disposed on the housing proximate the light source.	11-20-2008
20090085393	Inflatable Chair With Cushion Top - Disclosed herein is an inflatable chair having at least three sections. The inflatable chair has a lower inflatable support chamber that has a top and bottom layer. The inflatable chair also has an upper cushioning portion and a stabilizing member. The upper cushioning portion and the stabilizing member are in fluid communication with the lower inflatable support chamber. The inflatable chair is made of a high elastic PVC material.	04-02-2009
20110318194	PUMP WITH AUTOMATIC DEACTIVATION MECHANISM - An automatic deactivation mechanism is configured for an air bladder pump having a casing and a motor located therein to pump air into an air bladder from the atmosphere and through an air valve connected through the casing. The automatic deactivation mechanism includes a housing positioned within the casing and has defined therethrough a first aperture in fluid communication with the atmosphere through the casing and a second aperture in fluid communication with the air bladder through the casing. Included within the housing are at least two switches and a diaphragm positioned between the switches. The housing is sealed so that when a threshold pressure is reached therein, at least one switch is triggered by deflection of the diaphragm to automatically deactivate the pump by de-energizing the motor.	12-29-2011